Patents by Inventor Jérôme Denard

Jérôme Denard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VECTORS FOR THE TREATMENT OF ACID CERAMIDASE DEFICIENCY
    Publication number: 20230151390
    Abstract: The present invention relates to a vector comprising an ASAH1 open reading frame, for use in the treatment of acid ceramidase deficiency.
    Type: Application
    Filed: April 14, 2021
    Publication date: May 18, 2023
    Inventors: ANA BUJ BELLO, JÉRÔME DENARD, MARTINA MARINELLO
  • Methods of increasing efficiency of vector penetration of target tissue
    Patent number: 9546112
    Abstract: Methods for increasing the efficiency of target tissue penetration of an adeno-associated virus (AAV) vector in a patient are provided. In some aspects, the methods involve inhibiting the interaction of the serum protein galectin 3 binding protein (G3BP) with AAV vector. Further provided are methods for reducing tissue distribution of a virus or for neutralizing a virus harbored by an organ destined for transplant, or newly transplanted, by administering a composition comprising G3BP.
    Type: Grant
    Filed: March 22, 2011
    Date of Patent: January 17, 2017
    Assignees: ASSOCIATION INSTITUT DE MYOLOGIE, GÉNÉTHON, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITÉ PIERRE ET MARIE CURIE (PARIS 6), INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE
    Inventors: Thomas Voit, Luis Garcia, Jérôme Denard, Fedor Svinartchouk
  • METHODS OF INCREASING EFFICIENCY OF VECTOR PENETRATION OF TARGET TISSUE
    Publication number: 20130189225
    Abstract: Methods for increasing the efficiency of target tissue penetration of an adeno-associated virus (AAV) vector in a patient are provided. In some aspects, the methods involve inhibiting the interaction of the serum protein galectin 3 binding protein (G3BP) with AAV vector. Further provided are methods for reducing tissue distribution of a virus or for neutralizing a virus harbored by an organ destined for transplant, or newly transplanted, by administering a composition comprising G3BP.
    Type: Application
    Filed: March 22, 2011
    Publication date: July 25, 2013
    Applicants: ASSOCIATION INSTITUT DE MYOLOGIE, UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, GENETHON
    Inventors: Thomas Voit, Luis Garcia, Jérôme Denard, Fedor Svinartchouk